Temporal Trends in the Disease Burden of Colorectal Cancer with Its Risk Factors at the Global and National Level from 1990 to 2019 and Projections Until 2044

被引:18
|
作者
Liu, Yang [1 ]
Zhang, Chao [2 ]
Wang, Qianwen [1 ]
Wu, Kangze [3 ]
Sun, Zhouyi [1 ]
Tang, Zhe [1 ]
Zhang, Bo [3 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 4, Sch Med, Yiwu 322000, Zhejiang, Peoples R China
[2] Hubei Univ Med, Taihe Hosp, Ctr Evidence Based Med & Clin Res, Shiyan 442000, Hubei, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310000, Zhejiang, Peoples R China
来源
CLINICAL EPIDEMIOLOGY | 2023年 / 15卷
基金
中国国家自然科学基金;
关键词
global burden of disease; colorectal cancer; disability-adjusted life year; estimated annual percentage change; age-standardized incidence rate; Bayesian age-period-cohort; MORTALITY; SOCIETY; HEALTH; COHORT;
D O I
10.2147/CLEP.S388323
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: This study aimed to evaluate the global colorectal cancer(CRC) trend and the relevant risk factors from 1990 to 2019 and for better policymaking and resource allocation. Methods: Data on CRC, including incidence, mortality and disability adjusted life year (DALY) rates, were extracted from the 2019 Global Burden of Disease (GBD) study. The estimated annual percentage changes (EAPCs) were calculated to assess the temporal trend of incidence, mortality and DALYs. The Bayesian age-period-cohort model(BAPC) was used to predict the future burden of CRC. Results: In 2019, a total of 2.17 million CRC cases were reported worldwide, a 157% increase from 1990. In high-social demographic index (SDI) regions, the trend of age-standardized incidence rate(ASIR) tended to decrease, while the proportion of people under 50 years of age tended to increase. Although the number of deaths and DALYs increased, the age-standardized death rate (ASDR) and age-standardized DALY rate decreased. The CRC burden was growing fastest in middle-SDI regions, especially in East Asia, followed by low SDI regions. In addition, the milk intake, High-BMI and high fasting plasma glucose play a more important role in on CRC. The predicted cases and deaths in global continued to increase to 2044. And there is an upward trend in ASIR for both men and women. Conclusion: In developed regions, the CRC burden continues to decrease, while the CRC burden become more and more severe in developing regions. Overall, the burden of CRC will rising in the near future. Therefore, reasonable resource allocation and prevention policies should be implemented. Developing countries needs more attention.
引用
收藏
页码:55 / 71
页数:17
相关论文
共 50 条
  • [41] Disease burden of colorectal cancer attributable to dietary risk factors from 1990 to 2019 in China
    赵清雅
    张彩霞
    China Medical Abstracts(Internal Medicine), 2024, 41 (02) : 103 - 104
  • [42] Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039
    Yu, Jingru
    Yang, Xiaorong
    He, Wei
    Ye, Weimin
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (05) : 993 - 1001
  • [43] Spatiotemporal trends in global burden of rheumatic heart disease and associated risk factors from 1990 to 2019
    Zhang, Liang
    Tong, Zhuang
    Han, Ruizheng
    Li, Kaixiang
    Zhang, Xin
    Yuan, Ruixia
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 384 : 100 - 106
  • [44] Global burden of stomach cancer attributable to smoking from 1990 to 2019 and predictions to 2044
    Jia, Xiaoxiao
    Sheng, Chong
    Han, Xiaoxuan
    Li, Mengyuan
    Wang, Kaijuan
    PUBLIC HEALTH, 2024, 226 : 182 - 189
  • [45] Global, regional and national burden of rheumatoid arthritis, and attributable risk factors from 1990 to 2019: update from the Global Burden of Disease 2019 study
    Yang, Wei-Ming
    Xu, Yan-Mei
    Lin, Jin
    Liu, Jing
    Tan, Yuan-Fang
    Chen, Juan-Juan
    Wang, Xiao-Zhong
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (07) : 1516 - 1527
  • [46] Global trends and projections of colorectal, esophageal and stomach cancer burden among youth associated with diet: A analysis of 204 countries and territories from 1990 to 2019 and until 2040
    He, Ke-Jie
    Gong, Guoyu
    TRANSLATIONAL ONCOLOGY, 2024, 46
  • [47] National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019
    Armin Aryannejad
    Sahar Saeedi Moghaddam
    Baharnaz Mashinchi
    Mohammadreza Tabary
    Negar Rezaei
    Sarvenaz Shahin
    Nazila Rezaei
    Mohsen Naghavi
    Bagher Larijani
    Farshad Farzadfar
    Breast Cancer Research, 25
  • [48] National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019
    Aryannejad, Armin
    Moghaddam, Sahar Saeedi
    Mashinchi, Baharnaz
    Tabary, Mohammadreza
    Rezaei, Negar
    Shahin, Sarvenaz
    Rezaei, Nazila
    Naghavi, Mohsen
    Larijani, Bagher
    Farzadfar, Farshad
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [49] National Burden and Trends for 29 Groups of Cancer in Mexico from 1990 to 2019: A Secondary Analysis of the Global Burden of Disease Study 2019
    Beltran-Ontiveros, Saul A.
    Contreras-Gutierrez, Jose A.
    Lizarraga-Verdugo, Erik
    Gutierrez-Grijalva, Erick P.
    Lopez-Lopez, Kenia
    Lora-Fierro, Emilio H.
    Trujillo-Rojas, Miguel A.
    Moreno-Ortiz, Jose M.
    Cardoso-Angulo, Diana L.
    Leal-Leon, Emir
    Zatarain-Lopez, Jose R.
    Cuen-Diaz, Hector M.
    Montoya-Moreno, Marisol
    Arce-Bojorquez, Brisceyda
    Rochin-Teran, Juan L.
    Cuen-Lazcano, Daniel E.
    Contreras-Rodriguez, Victor A.
    Lascurain, Ricardo
    Carmona-Aparicio, Liliana
    Coballase-Urrutia, Elvia
    Gallardo-Vera, Francisco
    Diaz, Daniel
    CANCERS, 2024, 16 (01)
  • [50] The Global, Regional, and National Burden and Trends of Infective Endocarditis From 1990 to 2019: Results From the Global Burden of Disease Study 2019
    Chen, Huilong
    Zhan, Yuan
    Zhang, Kaimin
    Gao, Yiping
    Chen, Liyuan
    Zhan, Juan
    Chen, Zirui
    Zeng, Zhilin
    FRONTIERS IN MEDICINE, 2022, 9